Robotics

ReWalk Robotics (NASDAQ:LFWD) Shares Up 0.6%



ReWalk Robotics Ltd. (NASDAQ:LFWDGet Free Report) shot up 0.6% during mid-day trading on Wednesday . The company traded as high as $4.69 and last traded at $4.68. 13,188 shares traded hands during mid-day trading, a decline of 74% from the average session volume of 50,689 shares. The stock had previously closed at $4.65.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright increased their price objective on shares of ReWalk Robotics from $9.00 to $13.00 and gave the stock a “buy” rating in a research report on Thursday, May 16th.

Get Our Latest Stock Report on ReWalk Robotics

ReWalk Robotics Price Performance

The firm has a market capitalization of $40.25 million, a PE ratio of -1.51 and a beta of 2.12. The company’s 50 day simple moving average is $4.89.

ReWalk Robotics (NASDAQ:LFWDGet Free Report) last released its quarterly earnings results on Wednesday, May 15th. The company reported ($0.73) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.70) by ($0.03). The company had revenue of $5.28 million for the quarter, compared to analyst estimates of $5.55 million. ReWalk Robotics had a negative net margin of 134.52% and a negative return on equity of 35.41%. Research analysts expect that ReWalk Robotics Ltd. will post -1.94 EPS for the current year.

Hedge Funds Weigh In On ReWalk Robotics

A hedge fund recently bought a new stake in ReWalk Robotics stock. Kent Lake Capital LLC bought a new position in ReWalk Robotics Ltd. (NASDAQ:LFWDFree Report) during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 157,361 shares of the company’s stock, valued at approximately $823,000. Kent Lake Capital LLC owned about 1.85% of ReWalk Robotics as of its most recent SEC filing. 26.76% of the stock is owned by institutional investors and hedge funds.

ReWalk Robotics Company Profile

(Get Free Report)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.

See Also



Receive News & Ratings for ReWalk Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for ReWalk Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.



Source

Related Articles

Back to top button